Ozanimod

Generic name: Ozanimod
Brand names: Zeposia
Dosage form: oral capsule (0.23 mg-0.46 mg; 0.23 mg-0.46 mg-0.92 mg; 0.92 mg)
Drug class: Selective immunosuppressants

Usage of Ozanimod

Ozanimod is used to treat relapsing forms of multiple sclerosis in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease).

Ozanimod is used only if you have a specific genotype. Your doctor will test you for this genotype.

Ozanimod is also used to treat adults with moderately to severely active ulcerative colitis.

It is not known if this medicine is safe and effective in children.

Ozanimod side effects

Get emergency medical help if you have signs of an allergic reaction to ozanimod: hives, rash; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • slow heartbeats, chest pain, shortness of breath, or feel like your heart is skipping beats;
  • a light-headed feeling, like you might pass out;
  • cough, new or worsening shortness of breath;
  • sudden confusion, severe headache, vision loss, or a seizure;
  • pounding in your neck or ears;
  • liver problems - nausea, vomiting, upper stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
  • changes in vision - blurred vision, increased sensitivity to light, seeing an unusual color in your vision, or having a blind spot or shadows in the center of your vision; or
  • symptoms of infection - fever, flu symptoms, feeling very tired, cough, rash, painful and frequent urination, neck stiffness, increased sensitivity to light.
  • Common ozanimod side effects may include:

  • headache, back pain;
  • urination problems;
  • high or low blood pressure;
  • abnormal liver function tests; or
  • cold symptoms such as stuffy nose, sneezing, sore throat.
  • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Ozanimod

    You should not use ozanimod if you are allergic to it, or if you have certain serious heart conditions, especially:

  • recent (within the past 6 months) heart failure, heart attack, stroke, "mini-stroke" or TIA, chest pain (unstable angina), or other serious heart problem;
  • "AV block" or sick sinus syndrome (unless you have a pacemaker); or
  • severe untreated sleep apnea (breathing stops during sleep).
  • Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, or tranylcypromine. Wait at least 14 days after stopping an MAO inhibitor before you take ozanimod.

    Some heart rhythm medications can cause unwanted or dangerous effects when used with ozanimod. Your doctor may change your treatment plan if you also use amiodarone, disopyramide, dofetilide, dronedarone, ibutilide, procainamide, quinidine, or sotalol.

    Before you take ozanimod, tell your doctor if you have never had chickenpox or received a varicella vaccine (Varivax). You may need to receive the vaccine and then wait 1 month before taking this medicine.

    Tell your doctor if you have received any vaccine within the past 30 days, or if you are scheduled to receive a vaccine.

    Tell your doctor if you have a fever or infection, or if you have ever had:

  • a weak immune system (caused by disease or by using certain medicine);
  • a very slow heart rate;
  • heart rhythm problems, long QT syndrome;
  • a heart attack, stroke, or chest pain;
  • high blood pressure;
  • sleep apnea or other breathing problems;
  • diabetes;
  • liver disease; or
  • an eye condition called uveitis.
  • ozanimod may harm an unborn baby. Use effective birth control while using ozanimod and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

    If you are pregnant, your name may be listed on a pregnancy registry to track the effects of ozanimod on the baby.

    Ask a doctor if it is safe to breastfeed while using this medicine.

    Relate drugs

    How to use Ozanimod

    Usual Adult Dose for Multiple Sclerosis:

    DOSE TITRATION REGIMEN: -Days 1 through 4: 0.23 mg orally once a day -Days 5 through 7: 0.46 mg orally once daily -Day 8 and thereafter: 0.92 mg orally once a day MAINTENANCE DOSE: 0.92 mg orally once daily starting on Day 8 Uses: -For the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease -For the treatment of moderately to severely active ulcerative colitis

    Usual Adult Dose for Ulcerative Colitis:

    DOSE TITRATION REGIMEN: -Days 1 through 4: 0.23 mg orally once a day -Days 5 through 7: 0.46 mg orally once daily -Day 8 and thereafter: 0.92 mg orally once a day MAINTENANCE DOSE: 0.92 mg orally once daily starting on Day 8 Uses: -For the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease -For the treatment of moderately to severely active ulcerative colitis

    Warnings

    You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, flu symptoms, feeling very tired, cough, rash, painful and frequent urination, neck stiffness, increased sensitivity to light. Your risk of infection could last for 3 months after you stop taking ozanimod.

    You should not use ozanimod if you have a serious heart condition such as "AV block" or sick sinus syndrome and no pacemaker, or if you've recently had heart failure, a heart rhythm disorder, chest pain, heart attack, or stroke. You also should not use ozanimod if you have severe untreated sleep apnea.

    Do not use ozanimod if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine. Wait at least 14 days after stopping an MAO inhibitor before you take this medicine.

    Ozanimod can slow your heart rate when you start taking it. Tell your doctor if you have slow heartbeats, chest pain, shortness of breath, feeling like your heart is skipping beats.

    You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, aches, tiredness, cough, rash, painful and frequent urination, confusion, neck stiffness, or increased sensitivity to light. Your risk of infection could last for 3 months after you stop taking this medicine.

    What other drugs will affect Ozanimod

    Ozanimod can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.

    Tell your doctor about all your other medicines, especially:

  • alemtuzumab, clopidogrel, eltrombopag, gemfibrozil, rifampin;
  • an antidepressant;
  • drugs that weaken the immune system such as cancer medicine, steroids, and medicines to prevent organ transplant rejection;
  • heart rhythm medicine;
  • medicine to treat Parkinson's disease; or
  • opioid pain medicine.
  • This list is not complete and many other drugs may interact with ozanimod. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

    Ozanimod can have long lasting effects on your body, especially on your immune system. For at least 4 weeks after your last dose, tell any doctor who treats you that you have used this medicine.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords